Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters. (2023)

First Author: Casamajo AR
Attributed to:  Centre for Biocatalytic Manufacture of New Modalities (CBNM) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/jacs.3c07010

PubMed Identifier: 37782882

Publication URI: http://europepmc.org/abstract/MED/37782882

Type: Journal Article/Review

Volume: 145

Parent Publication: Journal of the American Chemical Society

Issue: 40

ISSN: 0002-7863